// App-Quantinova.ai

15439 2014 AHA : High Rates of antiplatelet Use in Atrial Fibrillation Patients Treated With Oral Anticoagulation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry

Researchers

Presenter

  • Narendra Singh

Principal Investigators

  • Jafna L Cox

  • Paul Dorian

  • Carl Fournier

  • G.B. John Mancini

  • Ashfaq Shuaib

  • Mahesh Kajil

  • Michelle Tsigoulis

  • Andrew C Ha

Medical Centers

  • Univ of Toronto, St Michael's Hosp, Toronto, ON, Canada

  • Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Georgia Regents Univ, augusta, GA.

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Canadian Cardiovascular Research Network, Brampton, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • University of Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Peripheral artery disease

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Arrhythmia

  • Stable coronary artery disease

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved